|
Status |
Public on May 31, 2018 |
Title |
NO2-CLA2 |
Sample type |
SRA |
|
|
Source name |
hCASMC
|
Organism |
Homo sapiens |
Characteristics |
cell type: human coronary artery smooth muscle cell passages: 5-6 agent: NO2-CLA
|
Treatment protocol |
The cells at 80% confluence were maintained in 0.5% FBS medium for overnight and subsequently treated with NO2-CLA, CLA or vehicle control for 6 hours
|
Growth protocol |
Human coronary artery smooth muscle cells (hCASMCs) were purchased from PromoCell (Germany) and cultured in Smooth Muscle Cell Growth Medium 2 from same company at 37 °C, 5% CO2 in a standard cell culture incubator
|
Extracted molecule |
total RNA |
Extraction protocol |
The total RNA from hCASMCs were isolated and purified using RNeasy mini kit (Qiagen) and subjected to on-column RNase-free DNase treatment following the manufacturer’s recommendation (Qiagen) RNA-seq library was prepared using the EnCore Complete RNA Seq Library System (NuGen, San Carlos, CA)
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina HiSeq 2000 |
|
|
Description |
cDNA sample from hCASMC cells treated with NO2-CLA, replicate 2
|
Data processing |
Read quality check using FastQC Read mapping to reference genome using Cufflinks, FPKM values were generated Genome_build: GRCh37 (Ensembl) Supplementary_files_format_and_content: fpkm_gene.txt
|
|
|
Submission date |
Jun 30, 2017 |
Last update date |
May 15, 2019 |
Contact name |
Shengdi Li |
E-mail(s) |
[email protected]
|
Organization name |
SIBS
|
Street address |
320 Yueyang Road
|
City |
Shanghai |
ZIP/Postal code |
200032 |
Country |
China |
|
|
Platform ID |
GPL11154 |
Series (1) |
GSE100676 |
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid |
|
Relations |
BioSample |
SAMN07303248 |
SRA |
SRX2973181 |